Fabry disease is a multisystemic, X-linked recessive lysosomal storage disease caused by decreased activity of alpha-galactosidase A that results in lysosomal accumulations of the glycosphingolipid GL-3. Progressive glycolipid accumulation is initially reversible but leads with time to tissue damage and later to organ failure in the third to the fourth decade and early death. It is an underdiagnosed condition leading to a delayed start of therapies and consequently to a lack of efficacy.Several aspects of the disease have been clarified by research but there still remains much to learn about specific issues. Practitioners should highly suspect Fabry disease in individuals presenting with the signs and symptoms mentioned above, along with the information gleaned from a thorough personal and family history and physical examination. Great effort has been made by screening studies, which should be extended to all the risk categories. The pathogenetic role of new mutations should be investigated. Preliminary studies have shown enzyme replacement therapy and chaperone therapy to be effective when started early. However, new therapies are coming on the horizon and this bodes well for the future of patients suffering from Fabry disease.
Giornale di Techniche Nefrologiche e Dialitiche – SAGE
Published: Mar 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera